We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Cellectricon Signs Collaboration Agreement with AstraZeneca

News   May 04, 2006

 
Cellectricon Signs Collaboration Agreement with AstraZeneca
 
 
 

RELATED ARTICLES

3D Microfluidic Platform Enables Neuronal Chemotactic Assays

News

Shedding light on neural regeneration mechanism by recognizing subtle variation in the gradient profiles of guidance molecules.

READ MORE


Clues for Drugging the "Undruggable"

News

Thalidomide analogs have been shown to mediate degradation of many more proteins than previously anticipated, which suggests that they could be rationally designed to target zinc finger transcription factors.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE